[Alveolar proteinosis. 2 cases with ultrastructural study].
D000111:Acetylcysteine / Q000627:therapeutic use; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001323:Autoantibodies; D001706:Biopsy; D001999:Bronchoscopy; D003371:Cough / Q000209:etiology; D004417:Dyspnea; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007122:Immunoelectrophoresis; D008074:Lipoproteins / Q000032:analysis; D008297:Male; D008854:Microscopy, Electron; D009088:Mucoproteins / Q000032:analysis; D009761:Nystatin / Q000627:therapeutic use; D010996:Pleural Effusion / Q000209:etiology; D011649:Pulmonary Alveolar Proteinosis; D011650:Pulmonary Alveoli / Q000473:pathology; D012129:Respiratory Function Tests; D013183:Sputum / Q000032:analysis; D014357:Trypsin / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D001323:Autoantibodies; D008074:Lipoproteins; D009088:Mucoproteins; D009761:Nystatin; D006493:Heparin; D014357:Trypsin; D000111:Acetylcysteine
La protéinose alvéolaire. Deux observations avec étude ultrastructurale.